Table 2. Response data: (A) General group; (B) analyses by previous chemotherapy.

Response	No. of patients	% of all patients	% of evaluable patients
(A)
CR	1	1	1
PR	27	31	35
OR	28	32 (22–42%)	36 (26–47%)
SD	18	21	23
PD	31	36	40
NE	10	11	—
(B)

No previous chemo. for MBC	No. of patients	No. of responses	% of all patients
Nil	24	9	38 (18–57)
1–5	63	19	30 (19–41)
Previous taxanes	25	5	20 (4–36%)

In brackets, 95% CI; CR=complete response; PR=partial response; SD=stable disease; PD=progressive disease; OR=overall response; NE=nonevaluable; chemo=chemotherapy; MBC=metastatic breast cancer.